THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Therapeutic Solutions International, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2018 to Q3 2024.
  • Therapeutic Solutions International, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 4.91B shares, a 49.5% increase year-over-year.
  • Therapeutic Solutions International, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 3.17B shares, a 25.3% increase from 2022.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 4.91B +1.63B +49.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-20
Q2 2024 4.51B +1.54B +51.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 3.95B +1.26B +46.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-30
Q4 2023 3.17B Oct 1, 2023 Dec 31, 2023 10-K 2024-04-17
Q3 2023 3.29B +721M +28.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-20
Q2 2023 2.98B +435M +17.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 2.69B Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-30
Q3 2022 2.57B Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 2.54B Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-21
Q1 2021 2.24B +345M +18.2% Jan 1, 2021 Mar 31, 2021 10-Q/A 2021-05-21
Q1 2020 1.9B 0 0% Jan 1, 2020 Mar 31, 2020 10-Q/A 2020-07-09
Q1 2019 1.9B +804M +73.7% Jan 1, 2019 Mar 31, 2019 10-Q/A 2021-05-21
Q1 2018 1.09B Jan 1, 2018 Mar 31, 2018 10-Q/A 2020-07-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.